Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Medicure (MCUJF) over the last 14 years, with Q2 2025 value amounting to -$1.2 million.

  • Medicure's Cash from Investing Activities fell 145184.3% to -$1.2 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 51002.15%. This contributed to the annual value of -$529012.5 for FY2024, which is 16674.08% down from last year.
  • Latest data reveals that Medicure reported Cash from Investing Activities of -$1.2 million as of Q2 2025, which was down 145184.3% from -$377728.7 recorded in Q1 2025.
  • In the past 5 years, Medicure's Cash from Investing Activities registered a high of -$19971.8 during Q1 2023, and its lowest value of -$1.6 million during Q4 2021.
  • For the 5-year period, Medicure's Cash from Investing Activities averaged around -$365077.5, with its median value being -$109757.5 (2022).
  • As far as peak fluctuations go, Medicure's Cash from Investing Activities soared by 7444.56% in 2022, and later plummeted by 145184.3% in 2025.
  • Over the past 5 years, Medicure's Cash from Investing Activities (Quarter) stood at -$1.6 million in 2021, then skyrocketed by 87.45% to -$206254.7 in 2022, then surged by 54.42% to -$94020.5 in 2023, then plummeted by 241.1% to -$320700.4 in 2024, then tumbled by 267.94% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q2 2025, -$377728.7 for Q1 2025, and -$320700.4 during Q4 2024.